How big is the Asia Pacific In Vitro Diagnostics Market?

The Asia Pacific In Vitro Diagnostics Market size is expected to reach USD 24.21 billion in 2024 and grow at a CAGR of 5.70% to reach USD 31.94 billion by 2029. Read More

What is the current Asia Pacific In Vitro Diagnostics Market size?

In 2024, the Asia Pacific In Vitro Diagnostics Market size is expected to reach USD 24.21 billion. Read More

Who are the key players in Asia Pacific In Vitro Diagnostics Market?

Abbott, Siemens Healthineers AG, bioMérieux SA, Thermo Fisher Scientific and F Hoffmann-La Roche Ltd are the major companies operating in the Asia Pacific In Vitro Diagnostics Market. Read More

What years does this Asia Pacific In Vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Asia Pacific In Vitro Diagnostics Market size was estimated at USD 22.83 billion. The report covers the Asia Pacific In Vitro Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia Pacific In Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Asia Pacific In Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 Asia Pacific In Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Asia Pacific In Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Asia Pacific In Vitro Diagnostics Industry

The Asia-Pacific in vitro diagnostics market is highly competitive and includes several major players. Regarding market share, a few major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products at lower prices. Some of the major players in the region are BioMérieux SA, Danaher (Beckman Coulter), F Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Abbott Laboratories, Arkray Inc., Sysmex Corporation, Ortho Clinical Diagnostics, Siemens Healthineers, Thermo Fischer Scientific Inc., and Qiagen NV.